Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Ming Hu

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|October 14, 2022
OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccinesRebekka Duhen, Michael Beymer, Shawn M Jensen, et al.
Immunology|February 27, 2003
Tumour-induced polarization of tumour vaccine-draining lymph node T cells to a type 1 cytokine profile predicts inherent strong immunogenicity of the tumour and correlates with therapeutic efficacy in adoptive transfer studiesHauke Winter, Hong-Ming Hu, Christian H Poehlein, et al.
Journal of Translational Medicine|June 15, 2006
Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor modelHong He, Preya Wisner, Guojun Yang, et al.
Oncoimmunology|December 8, 2018
Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancerRieneke van de Ven, Traci L Hilton, Hong-Ming Hu, et al.
Journal of Translational Medicine|November 16, 2007
Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokinesHauke Winter, Natasja K van den Engel, Dominik Rüttinger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2002
Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cellsSybren L Meijer, Annemieke Dols, Walter J Urba, et al.
Journal of Thoracic Disease|January 21, 2012
Active-specific immunotherapy for non-small cell lung cancerHauke Winter, Natasja K van den Engel, Margareta Rusan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2003
Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cellsAnnemieke Dols, Sybren L Meijer, Hong-Ming Hu, et al.
Cancer Immunology, Immunotherapy : CII|November 27, 2022
Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cellsSizhen Wang, Xiaohui Zhang, Xuemei Zou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cellsEdwin B Walker, Daniel Haley, William Miller, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|October 14, 2022
OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccinesRebekka Duhen, Michael Beymer, Shawn M Jensen, et al.
Immunology|February 27, 2003
Tumour-induced polarization of tumour vaccine-draining lymph node T cells to a type 1 cytokine profile predicts inherent strong immunogenicity of the tumour and correlates with therapeutic efficacy in adoptive transfer studiesHauke Winter, Hong-Ming Hu, Christian H Poehlein, et al.
Journal of Translational Medicine|June 15, 2006
Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor modelHong He, Preya Wisner, Guojun Yang, et al.
Oncoimmunology|December 8, 2018
Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancerRieneke van de Ven, Traci L Hilton, Hong-Ming Hu, et al.
Journal of Translational Medicine|November 16, 2007
Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokinesHauke Winter, Natasja K van den Engel, Dominik Rüttinger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2002
Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cellsSybren L Meijer, Annemieke Dols, Walter J Urba, et al.
Journal of Thoracic Disease|January 21, 2012
Active-specific immunotherapy for non-small cell lung cancerHauke Winter, Natasja K van den Engel, Margareta Rusan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2003
Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cellsAnnemieke Dols, Sybren L Meijer, Hong-Ming Hu, et al.
Cancer Immunology, Immunotherapy : CII|November 27, 2022
Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cellsSizhen Wang, Xiaohui Zhang, Xuemei Zou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cellsEdwin B Walker, Daniel Haley, William Miller, et al.
Pageof 8